Musculoskeletal analysis software developer Crescom and the Mass General Brigham (MGB) Department of Radiology in Boston have begun clinical validation of three MediAI pediatric tools.
The announcement marks Massachusetts General Hospital utilization of musculoskeletal AI, specifically bone age analysis AI MediAI-BA, full lower-limb length measurement AI MediAI-SG, and scoliosis severity auto-measurement AI MediAI-SC, according to Crescom.
MGB's studies are expected to serve as a pivotal milestone for South Korea-based Crescom to establish a robust clinical track record in the North American radiology and pediatric growth clinic markets, the company noted. MediAI-BA has received domestic regulatory approval in Korea, 510(k) clearance from the U.S. Food and Drug Administration (FDA), and regulatory approvals in Thailand and Malaysia, the company added.
